Go-to-market & commercialization strategy
Positioning, pricing, and ROI models that survive contact with a hospital CFO. Stakeholder analysis and buying-committee mapping — champion, economic buyer, IT, procurement — plus segmentation, launch playbooks, and the first reference customers.
Fractional medical affairs
KOL strategy and relationships, advisory boards designed to produce decisions, evidence generation plans, congress strategy, and publications. A physician leading the function part-time, until the full-time hire makes sense.
Clinical strategy & evidence
Study design, registries, and outcomes research that make the product credible — the same discipline behind an international 50-center trauma registry and validation studies that demonstrated double-digit survival improvement.
Partnerships & business development
Channel and health system partnerships, from target list to signed agreement. I have negotiated partnerships that secured over $1M in annual recurring revenue, and I know where these deals stall.
Investor & diligence support
Clinical and commercial diligence for investors, and exit-readiness for founders: evidence audit, adoption risk, sales-motion reality checks, and an honest read on what an acquirer will see.